Ronald Martell

Ronald Martell

Former Chief Executive Officer and PresidentatJasper Therapeutics· In proxies 2022–2025

Pay in FY2025-22% from the year before · Jasper Therapeutics stock -91.4% the same year

Ronald Martell was paid $2.5M in FY2025 (Dec), down 22%. Jasper Therapeutics stock fell 91.4% that year.

Pay$100 in the stock at the end of FY21 → $2
Pay is from the Summary Compensation Table of each Jasper Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Jasper TherapeuticsPublic company · 4 yr
    • Former Chief Executive Officer and President2022 – Present · 4 yrStock in role -99%
  2. MorphImmune, Inc.Public company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  3. Plus Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Cytori Therapeutics, Inc.Public company · 3 yr
    • Director2016 – 2019 · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?